MATK Products

Description

MATK, or Megakaryocyte-Associated Tyrosine-Protein Kinase, contains three isoforms that are 56 kDa, 57 kDa, and 52 kDa, and is involved in the regulation of tyrosine kinase and the inhibition of T-cell proliferation. MATK may play a role in signaling in certain types of breast cancer, and the protein is currently being used in research of a variety of diseases and disorders, including macular degeneration, endocarditis, neuroblastoma, colon cancer, ataxia, pharyngitis, pancreatitis, and pancreatic cancer. MATK is linked to the Kit Receptor signaling pathway, the IL-3 signaling pathway, the Neurotrophin signaling pathway, and ERBB2 signaling, through which it interacts with ERBB2, PTK2B, EWSR1, PXN, and SRC.

Bioinformatics

Product By Gene ID

4145

Alternate Names

CHK Csk-type protein tyrosine kinase CTKEC 2.7.10.2 DKFZp434N1212 EC 2.7.10 Hematopoietic consensus tyrosine-lacking kinase HHYLTK hydroxyaryl-protein kinase HYL tyrosine kinase HYLCsk-homologous kinase HYLTK leukocyte carboxyl-terminal src kinase related Lsk megakaryocyte-associated tyrosine kinase megakaryocyte-associated tyrosine-protein kinase MGC1708 MGC2101 Protein kinase HYL tyrosine kinase MATK Tyrosine-protein kinase CTK tyrosylprotein kinase

Research Areas for MATK

Find related products by research area and learn more about each of the different research areas below.

Cell Cycle and Replication